Cargando…
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system
Apelin and its G protein-coupled receptor (GPCR) have emerged as a key signalling pathway in the cardiovascular system. The peptide is a potent inotropic agent and vasodilator. Remarkably, a peptide, Elabela/Toddler, that has little sequence similarity to apelin, has been proposed as a second endoge...
Autores principales: | Yang, Peiran, Maguire, Janet J., Davenport, Anthony P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published By Elsevier In Association With The International Union Of Pharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577653/ https://www.ncbi.nlm.nih.gov/pubmed/26143239 http://dx.doi.org/10.1016/j.tips.2015.06.002 |
Ejemplares similares
-
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
por: Yang, Peiran, et al.
Publicado: (2017) -
Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
por: Liu, Wei, et al.
Publicado: (2020) -
International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand
por: Read, Cai, et al.
Publicado: (2019) -
Cardiac action of the first G protein biased small molecule apelin agonist
por: Read, Cai, et al.
Publicado: (2016) -
Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022)